These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9400991)

  • 1. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
    Pearson A; Greenblatt J
    Oncogene; 1997 Nov; 15(22):2643-58. PubMed ID: 9400991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment.
    Fry CJ; Pearson A; Malinowski E; Bartley SM; Greenblatt J; Farnham PJ
    J Biol Chem; 1999 May; 274(22):15883-91. PubMed ID: 10336493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of transcriptional activation and repression can both involve TFIID.
    Manley JL; Um M; Li C; Ashali H
    Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):517-26. PubMed ID: 8735274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
    Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
    Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of two novel cDNAs whose products associate with the amino terminus of the E2F1 transcription factor.
    Jordan KL; Evans DL; Steelman S; Hall DJ
    Biochemistry; 1996 Sep; 35(38):12320-8. PubMed ID: 8823166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM; Gall AL; Zheng N; Pavletich NP
    Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
    Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
    EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding.
    McEwan IJ; Dahlman-Wright K; Ford J; Wright AP
    Biochemistry; 1996 Jul; 35(29):9584-93. PubMed ID: 8755740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAFII-independent activation mediated by human TBP in the presence of the positive cofactor PC4.
    Wu SY; Kershnar E; Chiang CM
    EMBO J; 1998 Aug; 17(15):4478-90. PubMed ID: 9687514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of active transcriptional repression by the retinoblastoma protein.
    Weintraub SJ; Chow KN; Luo RX; Zhang SH; He S; Dean DC
    Nature; 1995 Jun; 375(6534):812-5. PubMed ID: 7596417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of TBP binding by activators and general transcription factors.
    Li XY; Virbasius A; Zhu X; Green MR
    Nature; 1999 Jun; 399(6736):605-9. PubMed ID: 10376604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma protein represses transcription by recruiting a histone deacetylase.
    Magnaghi-Jaulin L; Groisman R; Naguibneva I; Robin P; Lorain S; Le Villain JP; Troalen F; Trouche D; Harel-Bellan A
    Nature; 1998 Feb; 391(6667):601-5. PubMed ID: 9468140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
    Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
    Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of TBP to promoters in vivo is stimulated by activators and requires Pol II holoenzyme.
    Kuras L; Struhl K
    Nature; 1999 Jun; 399(6736):609-13. PubMed ID: 10376605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of E2F1 activity by acetylation.
    Martínez-Balbás MA; Bauer UM; Nielsen SJ; Brehm A; Kouzarides T
    EMBO J; 2000 Feb; 19(4):662-71. PubMed ID: 10675335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
    Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
    Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation.
    Kong HJ; Yu HJ; Hong S; Park MJ; Choi YH; An WG; Lee JW; Cheong J
    Mol Cancer Res; 2003 Nov; 1(13):948-58. PubMed ID: 14638867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.
    Nip J; Strom DK; Eischen CM; Cleveland JL; Zambetti GP; Hiebert SW
    Oncogene; 2001 Feb; 20(8):910-20. PubMed ID: 11314026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.